Stockscreener 앱 받기
307.37
1.09%
-3.41
Natera Inc 주식(NTRA)의 최신 뉴스
Natera (NTRA) Stock Looks Reasonable On Cash Flow But Rich On Sales - simplywall.st
5 Insightful Analyst Questions From Natera’s Q2 Earnings Call - StockStory
Natera at Canaccord Genuity conference: Signatera drives growth - Investing.com
NTRA Maintained by Stephens & Co. -- Price Target Raised to $350 - GuruFocus
Natera and Kupando Therapeutics Partner for Phase I Trial of KUP-101 in Advanced Skin Cancers - The Dermatology Digest
NTRA Maintained by Guggenheim -- Price Target Raised to $360 - GuruFocus
Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers - TradingView
Guggenheim Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $360 - Moomoo
Natera partners with Kupando for phase 1 cancer trial in Germany - Investing.com Australia
First Patient Dosed as Trial Tests Immunotherapy in Skin Cancers - Stock Titan
Technical Reactions to NTRA Trends in Macro Strategies - Stock Traders Daily
NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth - Yahoo Finance
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs - The Motley Fool
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests - The Motley Fool
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know - The Motley Fool
A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It - The Motley Fool
A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know - The Motley Fool
Natera Preps for MRD Test Expansion, Entry Into Early Cancer Detection on Heels of Recent Catalysts - 360Dx
Natera Insider Sold Shares Worth $2,888,325, According to a Recent SEC Filing - marketscreener.com
Natera (NTRA) Is Up 20.3% After Raising 2026 Guidance And Expanding Signatera’s Oncology Reach - simplywall.st
Natera (NTRA) Is Up 20.3% After Shelf Filing And Higher 2026 Guidance Has The Bull Case Changed? - Yahoo Finance
Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday - Sahm
NATERA, INC. : BERNSTEIN RAISES TARGET PRICE TO $365 FROM $310 - webull.com
Key facts: Natera, Inc. Q2 revenue $752.8M; JP Morgan raises PT to $360 - TradingView
Natera (NTRA) Stock Reprices Higher As Signatera Scale Starts Showing Up - Sahm
Natera Q2 2026 slides: revenue up 38%, guidance raised $100M - Investing.com South Africa
Natera’s Matthew Rabinowitz sells $641,800 in shares - Investing.com
Natera director Jonathan Sheena sells $2.89m in stock - Investing.com
Natera, Inc. (NTRA) chair logs 2,000-share sale via 10b5-1 plan - Stock Titan
Is Natera Inc (NTRA) Overvalued After 21.4% Rally? GF Value Says - GuruFocus
Natera Q2 2026 slides: record volumes drive 38% revenue growth By Investing.com - Investing.com Nigeria
Natera (NTRA) insider Rabinowitz files Form 144 for 2,000-share sale - Stock Titan
Natera, Inc. Stock 12‑Month Price Target Raised to $317.33, Implies 20% Upside - TradingView
Natera Shares Soar To All-Time High Cementing Chairman As Billionaire - forbes.com
Natera Stock Surges After Q2 Earnings Beat And Guidance Hike - StocksToTrade
Natera Stock Jumps After Q2 Beat And Guidance Hike - StocksToTrade
NTRA Surges As Natera Lifts 2026 Revenue Outlook - StocksToTrade
What To Know About This IBD 50 Stock's 'Blowout' Quarter - Investor's Business Daily
NTRA Stock Soars After Earnings Beat And Raised 2026 Outlook - StocksToTrade
Natera Stock Hits 52-Week HighHere's WhyNatera (NASDAQ:NTRA) - Benzinga
Natera Up Over 19%, On Pace for Record High Close -- Data Talk - Moomoo
NTRA Stock Surges After Big Earnings Beat And Guidance Hike - StocksToTrade
Natera (NASDAQ: NTRA) holder Jonathan Sheena plans 18,000-share stock sale - Stock Titan
Natera stock hits all-time high at 310.0 USD - Investing.com
RBC Capital Adjusts Price Target on Natera to $350 From $275, Maintains Outperform Rating - marketscreener.com
Natera, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Natera, Inc. 2026: Revenue $752.75M, EPS ($0.47) — 10-Q Summary - TradingView
Loss per share narrows as Natera (Nasdaq: NTRA) grows Q2 revenue - Stock Titan
Form 4 Natera Inc For: 6 August By Investing.com - Investing.com South Africa
Natera Reports Strong Q2 2026 Performance and Record Growth in Oncology - Oncodaily
NATERA, INC. : TD COWEN RAISES TARGET PRICE TO $340 FROM $325 - Bitget
Natera Q2 2026 slides: revenue up 38%, guidance raised on MRD surge - Investing.com
Natera Q2 Earnings Call Highlights - TradingView
Natera Inc (NTRA) (Q2 2026) Earnings Call Highlights: Record Volumes and Raised Guidance Signal ... - Yahoo Finance
Natera Inc earnings beat by $0.02, revenue topped estimates - Investing.com
Natera Q2 2026 slides: record volumes drive 38% revenue growth - Investing.com
Natera (NTRA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: Natera tops revenue view in Q2 2026, shares jump after hours - Investing.com
Is Natera Inc (NTRA) Valued Fairly After Q2 Earnings Miss? Reven - GuruFocus
Natera, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:NTRA) 2026-08-06 - Seeking Alpha
NATERA, INC. : CANACCORD GENUITY RAISES TARGET PRICE TO $375 FROM $330 - Bitget
Natera Inc (NTRA) Stock Down 3.4% but Still Overvalued -- GF Sco - GuruFocus
Natera: Q2 Earnings Snapshot - marketscreener.com
Natera (NASDAQ:NTRA) Reports Strong Q2 CY2026, Stock Jumps 16.3% - Yahoo Finance
Why Natera (NTRA) Stock Rose Today - Quiver Quantitative
Natera, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
2.00%
자본화:
|
볼륨(24시간):